Huang, Yue
Cai, Junjun
Ha, Fushuang
Guo, Beichen
Xin, Shaojie
Duan, Zhongping
Han, Tao
Funding for this research was provided by:
National 13th 5-Year Plan for Hepatitis Research (No.2017ZX10203201-007)
National Natural Science Foundation of China (No.81870429)
Natural Science Foundation of Tianjin (No.19JCZDJC36700)
Article History
Received: 28 January 2022
Accepted: 3 May 2022
First Online: 11 May 2022
Declarations
:
: This retrospective study was approved by the Ethics Committee of Tianjin Third Central Hospital, Beijing You’an Hospital Affiliated to Capital Medical University and the Fifth Medical Center of PLA General Hospital and conducted according to the principles of the Declaration of Helsinki (approved No. of ethic committee: SZX-IRB-SOP-016(F)-002-01). This trial was registered in the Chinese clinical trials registry: ChiCTR1900021539. We obtained written informed consent from all patients or their legal guardian.
: Not applicable.
: The authors declare no competing interests.